Keywords: آنتی ژن لوسکسی انسان; ADCC; antibody dependent cellular cytotoxicity; AML; acute myeloid leukemia; CMV; cytomegalovirus; CR; complete remission; HL; Hodgkin lymphoma; HLA; human leukocyte antigen; HLH; hemophagocytic lymphohistiocytosis; KIR; killer cell inhibitory immunoglobu
مقالات ISI آنتی ژن لوسکسی انسان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتی ژن لوسکسی انسان; CMP; common myeloid progenitor; GVHD; graft-vs-host disease; HLA; human leukocyte antigen; HSC; hematopoietic stem cell; HSCT; hematopoietic stem cell transplantation; IRI; ice recrystallization inhibitor; MEP; megakaryocyte-erythroid progenitor; MHC; maj
Keywords: آنتی ژن لوسکسی انسان; MDPI; Multidisciplinary Digital Publishing Institute; DOAJ; directory of open access journals; HLA; Human Leukocyte Antigen; IEDB; Immune Epitope Database; ABCpred; artificial neural network based B-cell epitope prediction; NIAID; National Institute of Al
Keywords: آنتی ژن لوسکسی انسان; Hepersensitivity; Severe cutaneous adverse reactions; Drug-induced liver injury; Human leukocyte antigen; Reactive metabolites; Hapten concept; p-i concept; Altered peptide repertory concept; APC; antigen presenting cell; BB; Bandrowski's base; DILI; drug
Keywords: آنتی ژن لوسکسی انسان; ECM; Extracellular matrix; EGFR; Epidermal growth factor receptor; GvHD; Graft versus host disease; HLA; Human leukocyte antigen; HSC; hematopoietic stem cells; LAB; Laser-assisted bioprinting; NOD; Non-obese diabetic; NSG; NOD SCID gamma; PBMC; Periphera
Keywords: آنتی ژن لوسکسی انسان; AD; Alzheimer'”s disease; Aβ; beta amyloid; ApoE4; apolipoprotein E4 genotype; T2DM; type 2 diabetes mellitus; GSK3β; glucose synthase kinase 3 beta; Drp1; dynamin-related protein1; ROS; reactive oxygen species; WHO; World Health Organization; ADA; Am
Keywords: آنتی ژن لوسکسی انسان; RSA; recurrent spontaneous abortion; CGH; comparative genomic hybridization; CNVs; copy number variations; IL; interleukin; SNP; single nucleotide polymorphism; bp; base pair; GO; gene ontology; HLA; human leukocyte antigen; Th1; T-helper1; Th2; T-helper2
Keywords: آنتی ژن لوسکسی انسان; donor allocation; heart transplantation; primary graft dysfunction; rejection; sensitization; survival; ACR; acute cellular rejection; AMR; antibody-mediated rejection; BiVAD; biventricular assist device; CIN; calcineurin inhibitor; CPRA; calculated panel
Keywords: آنتی ژن لوسکسی انسان; TME; tumour microenvironment; PD-1; programmed cell death 1; PD-L1; programmed death ligand 1; PD-L2; programmed death ligand 2; PTMs; post-translational histone modifications; DNMTi; DNA methyltransferase inhibitor; HDACi; histone deacetylase inhibitor;
Keywords: آنتی ژن لوسکسی انسان; CsA; cyclosporin A; ESRD; end-stage renal disease; HLA; human leukocyte antigen; LD; living donor; MALG; Minnesota antilymphocyte globulin; MMF; mycophenolate mofetil; PTLD; post-transplant lymphoproliferative disorder; SCr; serum creatinine;
Keywords: آنتی ژن لوسکسی انسان; gene sequencing; immunology; immunotherapy; tumor mutations; CTL; cytotoxic T lymphocyte; ELISPOT; enzyme-linked ImmunoSpot; HLA; human leukocyte antigen; MHC; major histocompatibility complex; PD-1; programmed cell death protein 1; pMHC; peptide MHC;
Keywords: آنتی ژن لوسکسی انسان; Systems biology; Immunotherapy; Cancer genomics; Whole exome sequencing; RNA sequencing; T-cell receptors; Neoantigens; HLA typing; Immuno-predictive score; CTL; Cytotoxic T-lymphocyte; HLA; Human leukocyte antigen; HTS; High-throughput sequencing; IHC; i
Keywords: آنتی ژن لوسکسی انسان; BCG vaccine; cancer vaccines; cell cycle checkpoints; immunotherapy; urologic neoplasms; AE; adverse event; APC; antigen presenting cell; BCG; bacillus Calmette-Guérin; CAR; chimeric antigen receptor; CIS; carcinoma in situ; CTA; cancer testis antigen; C
Keywords: آنتی ژن لوسکسی انسان; AA; Alopecia Areata; AID; autoimmune disease; Aire; autoimmune regulator; APC; antigen-presenting cells; APS; autoimmune polyendocrine syndrome; CeD; celiac disease; CTLA; cytotoxic T-lymphocyte-associated protein; CXCL; chemokine (C-X-C motif) ligand; DC
Keywords: آنتی ژن لوسکسی انسان; Human leukocyte antigen; T-cell receptor; Adverse drug reaction; Pharmacogenomics; Human herpes virus; Drug reaction with eosinophilia and systemic symptoms; Steven Johnson syndrome; Toxic epidermal necrolysis;
Keywords: آنتی ژن لوسکسی انسان; heart transplantation; calculated panel reactive antibody; waiting list; human leukocyte antigen; waiting time; sensitization;
Keywords: آنتی ژن لوسکسی انسان; CDMS; Clinically Definite Multiple Sclerosis; CI; Confidence Interval; CIS; Clinically Isolated Syndrome; CNS; Central Nervous System; EBV; Epstein-Barr Virus; GRADE; Grading of Recommendations Assessment, Development, and Evaluation; HLA; Human Leukocyte
Keywords: آنتی ژن لوسکسی انسان; Leukemia; Malnutrition; Soy protein; Whey protein; Protein intervention; PEM; Protein-energy malnutrition; HSCT; Hematopoietic stem cell transplantation; allo-HSCT; Allogeneic HSCT; BP; Soy-whey blended protein; ND; Natural diet; AML; Acute myeloid leukem
Keywords: آنتی ژن لوسکسی انسان; ADO; Autosomal dominant osteopetroses; ATP6V1B1; V-type proton ATPase subunit B, kidney isoform; CAII; carbonic anhydrase type II; Cas9; CRISPR associated protein 9; CLCN7; Chloride channel 7; CRISPR; clustered regularly interspaced short palindromic repe
Keywords: آنتی ژن لوسکسی انسان; heart transplantation; cardiac arrest; heart donor; heart recipient; outcome; CARD; cardiac arrestâresuscitated donor; CAV; cardiac allograft vasculopathy; ECMO; extracorporeal membrane oxygenation; EMB; endomyocardial biopsy; HLA; human leukocyte antig
Keywords: آنتی ژن لوسکسی انسان; EPT; enzyme prodrug therapy; NSC; neural stem cells; MSC; mesenchymal stromal cells; NK; natural killer cells; iPSCs; induced pluripotent stem cells; HSV-TK; herpes simplex virus thymidine kinase; GCV; ganciclovir; 5-FC; 5-Flurocytosine; 5-FU; 5-Flurouric
Keywords: آنتی ژن لوسکسی انسان; AD; atopic dermatitis; α2HS-GP; alpha-2-HS-glycoprotein; CCL20; C-C motif ligand 20; CCR2; C-C chemokine receptor type 2; CRP; C-reactive protein; CYA; ciclosporin; DC; dendritic cells; Dkk-1; dickkopf-related protein 1; dMVECs; dermal microvascular
Keywords: آنتی ژن لوسکسی انسان; Narcolepsy; Cataplexy; Orexin; Hypocretin; Neurodegeneration; Animal models; 5-HT; 5-hydroxytrytamine (serotonin); α1; noradrenergic alpha 1 receptor; α2; noradrenergic alpha 2 receptor; ACh; acetylcholine; Atax; orexin/ataxin-3 transgenic; BAC; bacteri
Keywords: آنتی ژن لوسکسی انسان; LSD; lysosomal storage disease; CNS; central nervous system; BBB; blood-brain barrier; ERT; enzyme replacement therapy; GAG; glycosaminoglycans; CSF; cerebrospinal fluid; FDA; food and drug administration; ICV; intracerebroventricular; HLA; human leukocyt
Keywords: آنتی ژن لوسکسی انسان; AS; ankylosing spondylitis; ASAS; Assessment of SpondyloArthritis International Society; AU; anterior uveitis; HLA; human leukocyte antigen; IBD; inflammatory bowel disease; SpA; spondyloarthritis;
Keywords: آنتی ژن لوسکسی انسان; AMR; antibody mediated rejection; DSA; donor specific antibodies; HLA; human leukocyte antigen; MFI; median fluorescence intensity; PRA; panel reactive antibody; PTC; peritubular capillaries; SAB; single-antigen bead; TG; transplant glomerulopathy; Acute
Keywords: آنتی ژن لوسکسی انسان; AMR; antibody mediated rejection; BAL; broncho-alveolar lavage; BOS; bronchiolitis obliterans syndrome; CLAD; chronic lung allograft syndrome; CT; computed tomography; DSA; donor specific antibodies; FEV1; forced expiratory volume in 1Â s; FVC; forced vit
Keywords: آنتی ژن لوسکسی انسان; APC; Allophycocyanin; CML; cell mediated lympholysis; cpm; counts per minute; CTL; cytotoxic T lymphocyte; E:T ratio; effector:target ratio; FITC; fluorescein isothiocyanate; HLA; human leukocyte antigen; IFN; interferon; IL; interleukin; MLC; mixed lymph
Keywords: آنتی ژن لوسکسی انسان; Genome-wide association study; Human leukocyte antigen; Pharmacogenomics; Schizophrenia; Side effect; Single nucleotide polymorphism;
Keywords: آنتی ژن لوسکسی انسان; Celiac disease; Human leukocyte antigen; Metabolomics; Early programming;
Keywords: آنتی ژن لوسکسی انسان; AUC; area under the curve; BB-DP; BioBreeding Diabetes-Prone; BB/OK; BioBreeding/Ottawa Kalsburg; cDM; canine diabetes mellitus; DM; diabetes mellitus; DLA; Dog Leukocyte Antigen; FPG; fasting plasma glucose; GIR; glucose infusion rate; GTT; glucose toler
Keywords: آنتی ژن لوسکسی انسان; bronchiolitis obliterans syndrome; hazard risk; human leukocyte antigen; induction therapy; lung transplantation; mismatch; obliterative bronchiolitis; survival;
Keywords: آنتی ژن لوسکسی انسان; WHO; World Health Organization; TNF; tumor necrosis factor; IL; interleukin; HSC; hematopoietic stem cell; NSG; NOD/SCID/γcâ/â; NK; natural killer; DC; dendritic cell; TCR; T cell receptor; DTH; delayed type hypersensitivity; HLA; human leukocyte ant
Keywords: آنتی ژن لوسکسی انسان; Magnesium; Lymphocyte; Transplantation; Hospital admission; CMV; cytomegalovirus; CNI; calcineurin inhibitor; DCD; donation after circulatory death; EBV; Epstein Barr virus; HLA; human leukocyte antigen; NK; natural killer; PCR; polymerase chain reaction;
Keywords: آنتی ژن لوسکسی انسان; AFND; Allele Frequency Net Database; BMDR; Bone Marrow Donor Registries; HLA; human leukocyte antigen; IMGT; the international ImMunoGeneTics information system; ID; identification; KIR; killer-cell immunoglobulin-like receptors; MICA; MHC class I polypep
Keywords: آنتی ژن لوسکسی انسان; Immune status; Pancreatic cancer; γδ T cells; Immune escape; Immune therapy; ADCC; antibody-dependent-cell mediated cytotoxicity; bsscFv; bispecific single-chain fragment variable; HD; healthy donor; HLA; human leukocyte antigen; NK cells; natural kille
Keywords: آنتی ژن لوسکسی انسان; ACLF; acute-on-chronic liver failure; AD; acute decompensating event; G-CSF; granulocyte colony stimulating factor; GM-CSF; granulocyte macrophage colony-stimulating factor; HIV; human immunodeficiency virus; HLA-DR; human leukocyte antigen; IL-1β; inter
Keywords: آنتی ژن لوسکسی انسان; AAs; autoantibodies; AAT; alpha-1 antitrypsin; BB; biobreeding rat strain; BBDP; biobreeding diabetes prone; BBDR; biobreeding diabetes resistant; ELISA; enzyme-linked immunosorbent assay; GI; gastrointestinal; HLA; human leukocyte antigen; HRS; high-risk
Keywords: آنتی ژن لوسکسی انسان; Familial myasthenia gravis; Elderly-onset; Human leukocyte antigen; Familial clustering;
Keywords: آنتی ژن لوسکسی انسان; AST; aspartate aminotransferase; BMI; body mass index; CI; confidence interval; CMV; cytomegalovirus; CNI; calcineurin inhibitor; CVA; cerebrovascular accident; DCD; donation after cardiac death; DM; diabetes mellitus; HLA; human leukocyte antigen; HTN; h
Keywords: آنتی ژن لوسکسی انسان; ACC; agenesis of the corpus callosum; aCGH; array comparative genomic hybridization; ADHD; Attention deficit hyperactivity disorder; ASD; autism spectrum disorders; BCAA; branched-chain amino acids; BCKD; branched-chain α-ketoacid dehydrogenase complex;
Keywords: آنتی ژن لوسکسی انسان; Coeliac disease; Gluten; Non-coeliac gluten sensitivity; Wheat allergy; ATI; amylase trypsin inhibitor; CD; coeliac disease; CU; contact urticaria; DH; dermatitis herpetiformis; ESPGHAN; European Society for Pediatric Gastroenterology, Hepatology and Nutr
Keywords: آنتی ژن لوسکسی انسان; AP-1; activator protein-1; AR; acute rejection; ATG; anti-thymocyte globulin; CAN; chronic allograft nephropathy; CBP; CREB-binding protein; CREB; cyclic AMP-responsive element-binding; DBD; DNA-binding domain; F2R; coagulation factor II receptor; FKBP; F
Keywords: آنتی ژن لوسکسی انسان; 3D; three-dimensional; ACI; autologous chondrocyte implantation; ACS; absorbable collagen sponge; AM; amniotic membrane; ASI; alternating solution immersion; ASCs; adipose-derived stem cells; BBIM; bioactive bone-inducing material; BM; basement membrane;
Keywords: آنتی ژن لوسکسی انسان; ACI; anemia of chronic inflammation; AD[H]D; attention deficit[/hyperactivity] disorder; ASD; autism spectrum disorder; BMS; burning mouth syndrome; BPAD; bipolar affective disorder; CCS; Cronkhite-Canada syndrome; CFS; chronic fatigue syndrome; CGRP; cal
Keywords: آنتی ژن لوسکسی انسان; G-CSF; Granulocyte-colony stimulating factor; GvD; Graft versus disease; GVHD; Graft-versus-host disease; HLA; Human leukocyte antigen; IgG kappa; Immunoglobulin G kappa; MRI; Magnetic resonance imaging; SCT; Stem cell transplantation; SM; Scleromyxedema;
Keywords: آنتی ژن لوسکسی انسان; Adverse drug reaction; drug-induced liver injury; hepatotoxicity; human leukocyte antigen; pharmacogenetics
Keywords: آنتی ژن لوسکسی انسان; Abs; antibodies; ATG; antithymocyte globulin; BSX; basiliximab; DSA; donor-specific antibody; DTT; dithiothreitol; ECZ; eculizumab; FC; flow cytometry; HLA; human leukocyte antigen; IVIg; intravenous immunoglobulin; LCT; lymphocytotoxicity; MoAbs; monoclo
Keywords: آنتی ژن لوسکسی انسان; Otosclerosis; Pathophysiology; Hearing loss; Stapes; HLA; Human Leukocyte Antigen; TGF-β; Transgrowing Growth Factor-β; BMP2/4; Bone Morphogenetic Proteins 2 and 4; SNP; Single Nucleotide Polymorphism; CD46/ CD150; Signaling lymphocytic activation molec
Keywords: آنتی ژن لوسکسی انسان; 27; 27.2; BIVAD; biventricular assist device; BTT; bridge to transplantation; HLA; human leukocyte antigen; HMII; HeartMate II left ventricular assist device; VAD; ventricular assist device;